Neyssa Marina

Professor of Pediatrics (Hematology/Oncology) at the Lucile Salter Packard Children's Hospital

Sarcoma Program

  • 875 Blake Wilbur Drive
  • Palo Alto, CA 94304
  • Phone: 650-498-6000
Learn More About the Clinic Getting Here Make An Appointment

Professional Education

Board Certification: Pediatrics, American Board of Pediatrics (1987)

MS, Stanford University, Epidemiology (2011)

Fellowship: St Jude Children's Research Hospital (1989) TN

Internship: University Pediatric Hospital (1984) Puerto Rico

Residency: University Pediatric Hospital (1986) Puerto Rico

Board Certification: Pediatric Hematology-Oncology, American Board of Pediatrics (1990)

Medical Education: University of Puerto Rico (1983) Puerto Rico

BS, University of PR, Mayaguez, Chemistry (1979)

MD, University of PR, Medicine (1983)

Residency, University of PR, Pediatrics (1986)

Fellowship, St. Jude Children's Hospital, Pediatric Hematology-Oncology (1989)

Honors & Awards

Alfa Omega Alfa Honor Society, Alfa Omega Alfa (1982)

Phi Kappa Phi Honor Society, Phi Kappa Phi (1979)

Magna Cum Laude-Antoine Lavoiser Chemistry Award, University of PR, Mayaguez Campus (1979)

Administrative Appointments

Oncology Section Chief, Stanford University, Division of Pediatric Hematology-Oncology (2013 - Present)

Associate Chief of Clinical Affairs, Pediatric Hematology-Oncology, Lucile Packard Children's Hospital (2006 - 2011)

Director, Pediatric Hematology-Oncology Fellowship Program, Stanford University (2000 - 2008)

Director of Hematology-Oncology Outpatient Clinic, Lucile Packard Children's Hospital (2000 - Present)

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

HER-2 expression is not prognostic in osteosarcoma; a Children's Oncology Group prospective biology study.
Gorlick, S., Barkauskas, D. A., Krailo, M., Piperdi, S., Sowers, R., & Marina, N. (2014). HER-2 expression is not prognostic in osteosarcoma; a Children's Oncology Group prospective biology study. Pediatric blood & cancer, 61(9), 1558-1564.

Symptom Assessment in Pediatric Oncology How Should Concordance Between Children's and Parents' Reports Be Evaluated?
Baggott, C., Cooper, B. A., Marina, N., Matthay, K. K., & Miaskowski, C. (2014). Symptom Assessment in Pediatric Oncology How Should Concordance Between Children's and Parents' Reports Be Evaluated?. CANCER NURSING, 37(4), 252-262.

Comparison of Latino and Non-Latino Patients With Ewing Sarcoma
Sharib, J., Horvai, A., Hazard, F. Kg., Daldrup-Link, H., Goldsby, R., & DuBois, S. G. (2014). Comparison of Latino and Non-Latino Patients With Ewing Sarcoma. PEDIATRIC BLOOD & CANCER, 61(2), 233-237.

Pilot study of cisplatin, etoposide, bleomycin, and escalating dose cyclophosphamide therapy for children with high risk germ cell tumors: A report of the children's oncology group (COG)
Malogolowkin, M. H., Krailo, M., Marina, N., Olson, T., & Frazier, A. L. (2013). Pilot study of cisplatin, etoposide, bleomycin, and escalating dose cyclophosphamide therapy for children with high risk germ cell tumors: A report of the children's oncology group (COG). PEDIATRIC BLOOD & CANCER, 60(10), 1602-1605.

Feasibility and dose discovery analysis of zoledronic acid with concurrent chemotherapy in the treatment of newly diagnosed metastatic osteosarcoma: A report from the Children's Oncology Group
Goldsby, R. E., Fan, T. M., Villaluna, D., Wagner, L. M., Isakoff, M. S., & Marina, N. (2013). Feasibility and dose discovery analysis of zoledronic acid with concurrent chemotherapy in the treatment of newly diagnosed metastatic osteosarcoma: A report from the Children's Oncology Group. EUROPEAN JOURNAL OF CANCER, 49(10), 2384-2391.

Children's Oncology Group's 2013 blueprint for research: Bone tumors
Gorlick, R., Janeway, K., Lessnick, S., Randall, R. L., & Marina, N. (2013). Children's Oncology Group's 2013 blueprint for research: Bone tumors. PEDIATRIC BLOOD & CANCER, 60(6), 1009-1015.

Changes in Health Status Among Aging Survivors of Pediatric Upper and Lower Extremity Sarcoma: A Report From the Childhood Cancer Survivor Study
Marina, N., Hudson, M. M., Jones, K. E., Mulrooney, D. A., Avedian, R., & Ness, K. K. (2013). Changes in Health Status Among Aging Survivors of Pediatric Upper and Lower Extremity Sarcoma: A Report From the Childhood Cancer Survivor Study. ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 94(6), 1062-1073.

Pediatric Acute Myeloid Leukemia as Classified Using 2008 WHO Criteria A Single-Center Experience
Davis, K. L., Marina, N., Arber, D. A., Ma, L., Cherry, A., & Heerema-McKenney, A. (2013). Pediatric Acute Myeloid Leukemia as Classified Using 2008 WHO Criteria A Single-Center Experience. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 139(6), 818-825.

A pilot study of low-dose anti-angiogenic chemotherapy in combination with standard multiagent chemotherapy for patients with newly diagnosed metastatic Ewing sarcoma family of tumors: A Children's Oncology Group (COG) Phase II study NCT00061893
Felgenhauer, J. L., Nieder, M. L., Krailo, M. D., Bernstein, M. L., Henry, D. W., & Marina, N. (2013). A pilot study of low-dose anti-angiogenic chemotherapy in combination with standard multiagent chemotherapy for patients with newly diagnosed metastatic Ewing sarcoma family of tumors: A Children's Oncology Group (COG) Phase II study NCT00061893. PEDIATRIC BLOOD & CANCER, 60(3), 409-414.

Genome-wide association study identifies two susceptibility loci for osteosarcoma.
Savage, S. A., Mirabello, L., Wang, Z., Gastier-Foster, J. M., Gorlick, R., & Chanock, S. J. (2013). Genome-wide association study identifies two susceptibility loci for osteosarcoma. Nature genetics.

Predictors of acute chemotherapy-associated toxicity in patients with Ewing sarcoma
Sharib, J. M., Cyrus, J., Horvai, A., Hazard, F. Kg., Neuhaus, J., & DuBois, S. G. (2012). Predictors of acute chemotherapy-associated toxicity in patients with Ewing sarcoma. PEDIATRIC BLOOD & CANCER, 59(4), 611-616.

Outcome for adolescent and young adult patients with osteosarcoma
Janeway, K. A., Barkauskas, D. A., Krailo, M. D., Meyers, P. A., Schwartz, C. L., & Marina, N. (2012). Outcome for adolescent and young adult patients with osteosarcoma. CANCER, 118(18), 4597-4605.

Phase II Trial of Trastuzumab in Combination With Cytotoxic Chemotherapy for Treatment of Metastatic Osteosarcoma With Human Epidermal Growth Factor Receptor 2 Overexpression: A Report From the Children's Oncology Group
Ebb, D., Meyers, P., Grier, H., Bernstein, M., Gorlick, R., & Marina, N. (2012). Phase II Trial of Trastuzumab in Combination With Cytotoxic Chemotherapy for Treatment of Metastatic Osteosarcoma With Human Epidermal Growth Factor Receptor 2 Overexpression: A Report From the Children's Oncology Group. JOURNAL OF CLINICAL ONCOLOGY, 30(20), 2545-2551.

Symptom Cluster Analyses Based on Symptom Occurrence and Severity Ratings Among Pediatric Oncology Patients During Myelosuppressive Chemotherapy
Baggott, C., Cooper, B. A., Marina, N., Matthay, K. K., & Miaskowski, C. (2012). Symptom Cluster Analyses Based on Symptom Occurrence and Severity Ratings Among Pediatric Oncology Patients During Myelosuppressive Chemotherapy. CANCER NURSING, 35(1), 19-28.

Body Mass Index (BMI) at Diagnosis Is Associated With Surgical Wound Complications in Patients With Localized Osteosarcoma: A Report From the Children's Oncology Group
Hingorani, P., Seidel, K., Krailo, M., Mascarenhas, L., Meyers, P., & Hawkins, D. S. (2011). Body Mass Index (BMI) at Diagnosis Is Associated With Surgical Wound Complications in Patients With Localized Osteosarcoma: A Report From the Children's Oncology Group. PEDIATRIC BLOOD & CANCER, 57(6), 939-942.

High-Intensity Focused Ultrasound (HIFU) Is Not Indicated for Treatment of Primary Bone Sarcomas
Bielack, S. S., Marina, N., & Bernstein, M. (2011). High-Intensity Focused Ultrasound (HIFU) Is Not Indicated for Treatment of Primary Bone Sarcomas. CANCER, 117(12), 2822-2822.

An evaluation of the factors that affect the health-related quality of life of children following myelosuppressive chemotherapy
Baggott, C. R., Dodd, M., Kennedy, C., Marina, N., Matthay, K. K., & Miaskowski, C. (2011). An evaluation of the factors that affect the health-related quality of life of children following myelosuppressive chemotherapy. SUPPORTIVE CARE IN CANCER, 19(3), 353-361.

Twenty Years of Follow-Up of Survivors of Childhood Osteosarcoma
Nagarajan, R., Kamruzzaman, A., Ness, K. K., Marchese, V. G., Sklar, C., & Marina, N. (2011). Twenty Years of Follow-Up of Survivors of Childhood Osteosarcoma. CANCER, 117(3), 625-634.

Changes in Children's Reports of Symptom Occurrence and Severity During a Course of Myelosuppressive Chemotherapy
Baggott, C., Dodd, M., Kennedy, C., Marina, N., Matthay, K. K., & Miaskowski, C. (2010). Changes in Children's Reports of Symptom Occurrence and Severity During a Course of Myelosuppressive Chemotherapy. JOURNAL OF PEDIATRIC ONCOLOGY NURSING, 27(6), 307-315.

Inhaled Granulocyte-Macrophage Colony Stimulating Factor for First Pulmonary Recurrence of Osteosarcoma: Effects on Disease-Free Survival and Immunomodulation. A Report From the Children's Oncology Group
Arndt, C. As., Koshkina, N. V., Inwards, C. Y., Hawkins, D. S., Krailo, M. D., & Kleinerman, E. S. (2010). Inhaled Granulocyte-Macrophage Colony Stimulating Factor for First Pulmonary Recurrence of Osteosarcoma: Effects on Disease-Free Survival and Immunomodulation. A Report From the Children's Oncology Group. CLINICAL CANCER RESEARCH, 16(15), 4024-4030.

Current Treatment Protocols Have Eliminated the Prognostic Advantage of Type 1 Fusions in Ewing Sarcoma: A Report From the Children's Oncology Group
van Doorninck, J. A., Ji, L., Schaub, B., Shimada, H., Wing, M. R., & Lawlor, E. R. (2010). Current Treatment Protocols Have Eliminated the Prognostic Advantage of Type 1 Fusions in Ewing Sarcoma: A Report From the Children's Oncology Group. JOURNAL OF CLINICAL ONCOLOGY, 28(12), 1989-1994.

The Role of Interferons in the Treatment of Osteosarcoma
Whelan, J., Patterson, D., Perisoglou, M., Bielack, S., Marina, N., & Bernstein, M. (2010). The Role of Interferons in the Treatment of Osteosarcoma. PEDIATRIC BLOOD & CANCER, 54(3), 350-354.

Knowledge of Hepatitis C Virus Screening in Long-Term Pediatric Cancer Survivors A Report From the Childhood Cancer Survivor Study
Lansdale, M., Castellino, S., Marina, N., Goodman, P., Hudson, M. M., & Oeffinger, K. C. (2010). Knowledge of Hepatitis C Virus Screening in Long-Term Pediatric Cancer Survivors A Report From the Childhood Cancer Survivor Study. CANCER, 116(4), 974-982.

Angiogenesis and Vascular Targeting in Ewing Sarcoma A Review of Preclinical and Clinical Data
DuBois, S. G., Marina, N., & Glade-Bender, J. (2010). Angiogenesis and Vascular Targeting in Ewing Sarcoma A Review of Preclinical and Clinical Data. CANCER, 116(3), 749-757.

Multiple Symptoms in Pediatric Oncology Patients: A Systematic Review
Baggott, C., Dodd, M., Kennedy, C., Marina, N., & Miaskowski, C. (2009). Multiple Symptoms in Pediatric Oncology Patients: A Systematic Review. JOURNAL OF PEDIATRIC ONCOLOGY NURSING, 26(6), 325-339.

Dose-Intensified Compared With Standard Chemotherapy for Nonmetastatic Ewing Sarcoma Family of Tumors: A Children's Oncology Group Study
Granowetter, L., Womer, R., Devidas, M., Krailo, M., Wang, C., & Grier, H. E. (2009). Dose-Intensified Compared With Standard Chemotherapy for Nonmetastatic Ewing Sarcoma Family of Tumors: A Children's Oncology Group Study. JOURNAL OF CLINICAL ONCOLOGY, 27(15), 2536-2541.

Immune approaches to treating osteosarcoma
Marina, N., & Gorlick, R. (2009). Immune approaches to treating osteosarcoma. CANCER BIOLOGY & THERAPY, 8(10), 981-983.

Physical Performance Limitations in the Childhood Cancer Survivor Study Cohort
Ness, K. K., Hudson, M. M., Ginsberg, J. P., Nagarajan, R., Kaste, S. C., & Gurney, J. G. (2009). Physical Performance Limitations in the Childhood Cancer Survivor Study Cohort. JOURNAL OF CLINICAL ONCOLOGY, 27(14), 2382-2389.

Phase II Study of Intermediate-Dose Cytarabine in Patients With Relapsed or Refractory Ewing Sarcoma: A Report From the Children's Oncology Group
DuBois, S. G., Krailo, M. D., Lessnick, S. L., Smith, R., Chen, Z., & Stegmaier, K. (2009). Phase II Study of Intermediate-Dose Cytarabine in Patients With Relapsed or Refractory Ewing Sarcoma: A Report From the Children's Oncology Group. PEDIATRIC BLOOD & CANCER, 52(3), 324-327.

International Collaboration is Feasible in Trials for Rare Conditions: The EURAMOS Experience
Marina, N., Bielack, S., Whelan, J., Smeland, S., Krailo, M., & Bernstein, M. (2009). International Collaboration is Feasible in Trials for Rare Conditions: The EURAMOS Experience. PEDIATRIC AND ADOLESCENT OSTEOSARCOMA, 152, 339-353.

Renal function after ifosfamide, carboplatin and etoposide (ICE) chemotherapy, nephrectomy and radiotherapy in children with wilms tumour
Daw, N. C., Gregornik, D., Rodman, J., Marina, N., Wu, J., & Jones, D. P. (2009). Renal function after ifosfamide, carboplatin and etoposide (ICE) chemotherapy, nephrectomy and radiotherapy in children with wilms tumour. EUROPEAN JOURNAL OF CANCER, 45(1), 99-106.

Anti-insulin growth factor receptor therapy in Ewing sarcoma.
Isakoff, M. S., & Marina, N. (2009). Anti-insulin growth factor receptor therapy in Ewing sarcoma. F1000 medicine reports.

Second Solid Malignancies Among Children, Adolescents, and Young Adults Diagnosed With Malignant Bone Tumors After 1976 Follow-Up of a Children's Oncology Group Cohort
Goldsby, R., Burke, C., Nagarajan, R., Zhou, T., Chen, Z., & Bhatia, S. (2008). Second Solid Malignancies Among Children, Adolescents, and Young Adults Diagnosed With Malignant Bone Tumors After 1976 Follow-Up of a Children's Oncology Group Cohort. CANCER, 113(9), 2597-2604.

Prognostic factors for patients with Ewing sarcoma (EWS) at first recurrence following multi-modality therapy: A report from the Children's Oncology Group
Leavey, P. J., Mascarenhas, L., Marina, N., Chen, Z., Krailo, M., & Grier, H. E. (2008). Prognostic factors for patients with Ewing sarcoma (EWS) at first recurrence following multi-modality therapy: A report from the Children's Oncology Group. PEDIATRIC BLOOD & CANCER, 51(3), 334-338.

Imaging guidelines for children with Ewing sarcoma and osteosarcoma: A report from the Children's Oncology Group Bone Tumor Committee
Meyer, J. S., Nadel, H. R., Marina, N., Womer, R. B., Brown, K. Lb., & Kailo, M. D. (2008). Imaging guidelines for children with Ewing sarcoma and osteosarcoma: A report from the Children's Oncology Group Bone Tumor Committee. PEDIATRIC BLOOD & CANCER, 51(2), 163-170.

Osteosarcoma: The same old drugs or more?
Bielack, S. S., Marina, N., Ferrari, S., Helman, L. J., Smeland, S., & Reaman, G. H. (2008). Osteosarcoma: The same old drugs or more?. JOURNAL OF CLINICAL ONCOLOGY, 26(18), 3102-3103.

Application of the adult International Germ Cell Classification system to pediatric malignant non-seminomatous germ cell tumors: A report from the children's oncology group
Frazier, A. L., Rumcheva, P., Olson, T., Giller, R., Cushing, B., & London, W. B. (2008). Application of the adult International Germ Cell Classification system to pediatric malignant non-seminomatous germ cell tumors: A report from the children's oncology group. PEDIATRIC BLOOD & CANCER, 50(4), 746-751.

Monitoring for cardiovascular disease in survivors of childhood cancer: Report from the cardiovascular disease task force of the children's oncology group
Shankar, S. M., Marina, N., Hudson, M. M., Hodgson, D. C., Adams, M. J., & Rosenthal, D. (2008). Monitoring for cardiovascular disease in survivors of childhood cancer: Report from the cardiovascular disease task force of the children's oncology group. PEDIATRICS, 121(2), E387-E396.

Complementary and alternative therapy use in adult survivors of childhood cancer: A report from the childhood cancer survivor study
Mertens, A. C., Sencer, S., Myers, C. D., Recklitis, C., Kadan-Lottick, N., & Zeltzer, L. (2008). Complementary and alternative therapy use in adult survivors of childhood cancer: A report from the childhood cancer survivor study. PEDIATRIC BLOOD & CANCER, 50(1), 90-97.

Challenges in the recruitment of adolescents and young adults to cancer clinical trials
Burke, M. E., Albritton, K., & Marina, N. (2007). Challenges in the recruitment of adolescents and young adults to cancer clinical trials. CANCER, 110(11), 2385-2393.

Noninvasive evaluation of late anthracycline cardiac toxicity in childhood cancer survivors
Hudson, M. M., Rai, S. N., Nunez, C., Merchant, T. E., Marina, N. M., & Rosenthal, D. (2007). Noninvasive evaluation of late anthracycline cardiac toxicity in childhood cancer survivors. JOURNAL OF CLINICAL ONCOLOGY, 25(24), 3635-3643.

Chronic health conditions in adult survivors of childhood cancer
Oeffinger, K. C., Mertens, A. C., Sklar, C. A., Kawashima, T., Hudson, M. M., & Robison, L. L. (2006). Chronic health conditions in adult survivors of childhood cancer. NEW ENGLAND JOURNAL OF MEDICINE, 355(15), 1572-1582.

Prognostic factors in children with extragonadal malignant germ cell tumors: A pediatric intergroup study
Marina, N., London, W. B., Frazier, A. L., Lauer, S., Rescorla, F., & Olson, T. (2006). Prognostic factors in children with extragonadal malignant germ cell tumors: A pediatric intergroup study. JOURNAL OF CLINICAL ONCOLOGY, 24(16), 2544-2548.

Amifostine does not protect against the ototoxicity of high-dose cisplatin combined with etoposide and bleomycin in pediatric germ-cell tumors - A children's Oncology Group study
Marina, N., Chang, K. W., Malogolowkin, M., London, W. B., Frazier, A. L., & Olson, T. A. (2005). Amifostine does not protect against the ototoxicity of high-dose cisplatin combined with etoposide and bleomycin in pediatric germ-cell tumors - A children's Oncology Group study. CANCER, 104(4), 841-847.

High-dose therapy and stem-cell rescue for Ewing's family of tumors in second remission
Marina, N., & Meyers, P. A. (2005). High-dose therapy and stem-cell rescue for Ewing's family of tumors in second remission. JOURNAL OF CLINICAL ONCOLOGY, 23(19), 4262-4264.

Low levels of Her2/neu expressed by Ewing's family tumor cell lines can redirect cytokine-induced killer cells
Verneris, M. R., Arshi, A., Edinger, M., Kornacker, M., Natkunam, Y., & Negrin, R. S. (2005). Low levels of Her2/neu expressed by Ewing's family tumor cell lines can redirect cytokine-induced killer cells. CLINICAL CANCER RESEARCH, 11(12), 4561-4570.

Development of risk-based guidelines for pediatric cancer survivors: The Children's Oncology Group Long-Term Follow-Up Guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline
Landier, W., Bhatia, S., Eshelman, D. A., Forte, K. J., Sweeney, T., & Hudson, M. M. (2004). Development of risk-based guidelines for pediatric cancer survivors: The Children's Oncology Group Long-Term Follow-Up Guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline. JOURNAL OF CLINICAL ONCOLOGY, 22(24), 4979-4990.

Treatment of children and adolescents with stage II testicular and stages I and II ovarian malignant germ cell tumors: A pediatric intergroup study - Pediatric oncology group 9048 and children's cancer group 8891
Rogers, P. C., Olson, T. A., Cullen, J. W., Billmire, D. F., Marina, N., & Cushing, B. (2004). Treatment of children and adolescents with stage II testicular and stages I and II ovarian malignant germ cell tumors: A pediatric intergroup study - Pediatric oncology group 9048 and children's cancer group 8891. JOURNAL OF CLINICAL ONCOLOGY, 22(17), 3563-3569.

Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: A pediatric intergroup study - Pediatric Oncology Group 9049 and Children's Cancer Group 8882
Cushing, B., Giller, R., Cullen, J. W., Marina, N. M., Lauer, S. J., & Castleberry, R. P. (2004). Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: A pediatric intergroup study - Pediatric Oncology Group 9049 and Children's Cancer Group 8882. JOURNAL OF CLINICAL ONCOLOGY, 22(13), 2691-2700.

Biology and therapeutic advances for pediatric osteosarcoma
Marina, N., Gebhardt, M., Teot, L., & Gorlick, R. (2004). Biology and therapeutic advances for pediatric osteosarcoma. ONCOLOGIST, 9(4), 422-441.

Biology of childhood osteogenic sarcoma and potential targets for therapeutic development: Meeting summary
Gorlick, R., Anderson, P., Andrulis, I., Arndt, C., Beardsley, G. P., & Anderson, B. (2003). Biology of childhood osteogenic sarcoma and potential targets for therapeutic development: Meeting summary. CLINICAL CANCER RESEARCH, 9(15), 5442-5453.

Health status of adult long-term survivors of childhood cancer - A report from the childhood cancer survivor study
Hudson, A. M., Mertens, A. C., Yasui, Y., Hobbie, W., Chen, H. G., & Oeffinger, K. C. (2003). Health status of adult long-term survivors of childhood cancer - A report from the childhood cancer survivor study. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 290(12), 1583-1592.

Dose escalation and pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in children with solid tumors: A pediatric oncology group study
Marina, N. M., Cochrane, D., Harney, E., Zomorodi, K., Blaney, S., & Link, M. P. (2002). Dose escalation and pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in children with solid tumors: A pediatric oncology group study. CLINICAL CANCER RESEARCH, 8(2), 413-418.

Letter to the editor: Recurrent mercaptopurine-induced acute pancreatitis: A rare complication of chemotherapy for acute lymphoblastic leukemia in children
Willert, J. R., Dahl, G. V., & Marina, N. M. (2002). Letter to the editor: Recurrent mercaptopurine-induced acute pancreatitis: A rare complication of chemotherapy for acute lymphoblastic leukemia in children. MEDICAL AND PEDIATRIC ONCOLOGY, 38(1), 73-74.

New molecular targets and biological therapies in sarcomas
Scappaticci, F. A., & Marina, N. (2001). New molecular targets and biological therapies in sarcomas. CANCER TREATMENT REVIEWS, 27(6), 317-326.

Carboplatin/ifosfamide window therapy for osteosarcoma: Results of the St Jude Children's Research Hospital OS-91 trial
Meyer, W. H., Pratt, C. B., Poquette, C. A., Rao, B. N., Parham, D. M., & Fletcher, B. D. (2001). Carboplatin/ifosfamide window therapy for osteosarcoma: Results of the St Jude Children's Research Hospital OS-91 trial. JOURNAL OF CLINICAL ONCOLOGY, 19(1), 171-182.

Acute lymphoblastic leukemia in a developing country: Preliminary results of a nonrandomized clinical trial in El Salvador
Bonilla, M., Moreno, N., Marina, N., deReyes, G., Shurtleff, S. A., & Antillon, F. G. (2000). Acute lymphoblastic leukemia in a developing country: Preliminary results of a nonrandomized clinical trial in El Salvador. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 22(6), 495-501.

Abnormalities of the thyroid in survivors of Hodgkin's disease: Data from the childhood cancer survivor study
Sklar, C., Whitton, J., Mertens, A., Stovall, M., Green, D., & Robison, L. (2000). Abnormalities of the thyroid in survivors of Hodgkin's disease: Data from the childhood cancer survivor study. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 85(9), 3227-3232.

Hematologic abnormalities and acute myeloid leukemia in children and adolescents administered intensified chemotherapy for the Ewing sarcoma family of tumors
Rodriguez-Galindo, C., Poquette, C. A., Marina, N. M., Head, D. R., Cain, A., & Pappo, A. S. (2000). Hematologic abnormalities and acute myeloid leukemia in children and adolescents administered intensified chemotherapy for the Ewing sarcoma family of tumors. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 22(4), 321-329.

Comparative renal tubular toxicity of chemotherapy regimens including ifosfamide in patients with newly diagnosed sarcomas
Marina, N. M., Poquette, C. A., Cain, A. M., Jones, D., Pratt, C. B., & Meyer, W. H. (2000). Comparative renal tubular toxicity of chemotherapy regimens including ifosfamide in patients with newly diagnosed sarcomas. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 22(2), 112-118.

Surgical resection alone is effective treatment for ovarian immature teratoma in children and adolescents: A report of the Pediatric Oncology Group and the Children's Cancer Group
Cushing, B., Giller, R., Ablin, A., Cohen, L., Cullen, J., & Castleberry, R. P. (1999). Surgical resection alone is effective treatment for ovarian immature teratoma in children and adolescents: A report of the Pediatric Oncology Group and the Children's Cancer Group. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 181(2), 353-358.

Complete surgical excision is effective treatment for children with immature teratomas with or without malignant elements: A pediatric oncology group/children's cancer group intergroup study
Marina, N. M., Cushing, B., Giller, R., Cohen, L., Lauer, S. J., & Castleberry, R. P. (1999). Complete surgical excision is effective treatment for children with immature teratomas with or without malignant elements: A pediatric oncology group/children's cancer group intergroup study. JOURNAL OF CLINICAL ONCOLOGY, 17(7), 2137-2143.

Late effects of treatment for germ cell tumors during childhood and adolescence
Hale, G. A., Marina, N. M., Jones-Wallace, D., Greenwald, C. A., Jenkins, J. J., & Hudson, M. M. (1999). Late effects of treatment for germ cell tumors during childhood and adolescence. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 21(2), 115-122.

Biology and therapy of pediatric malignant solid tumors.
Marina, N. (1999). Biology and therapy of pediatric malignant solid tumors. Cancer chemotherapy and biological response modifiers, 18, 550-589.

Chemotherapy dose-intensification for pediatric patients with Ewing's family of tumors and desmoplastic small round-cell tumors: A feasibility study at St. Jude Children's Research Hospital
Marina, N. M., Pappo, A. S., Parham, D. M., Cain, A. M., Rao, B. N., & Meyer, W. H. (1999). Chemotherapy dose-intensification for pediatric patients with Ewing's family of tumors and desmoplastic small round-cell tumors: A feasibility study at St. Jude Children's Research Hospital. JOURNAL OF CLINICAL ONCOLOGY, 17(1), 180-190.

Wilms' tumour. Optimal treatment strategies.
Suryanarayan, K., & Marina, N. (1998). Wilms' tumour. Optimal treatment strategies. Drugs, 56(4), 598-605.

Wilms' tumour - Optimal treatment strategies
Suryanarayan, K., & Marina, N. (1998). Wilms' tumour - Optimal treatment strategies. DRUGS, 56(4), 597-605.

Peritoneal metastases in children with cancer
Kaste, S. C., Marina, N., Fryrear, R., Hedlund, G. L., Jones, L., & Jenkins, J. J. (1998). Peritoneal metastases in children with cancer. CANCER, 83(2), 385-390.

Nongestational choriocarcinoma in the postpartum period: A case report
Suryanarayan, K., O'Hanlan, K. A., Surti, U., Ishwad, C. S., Nowels, K., & Marina, N. (1998). Nongestational choriocarcinoma in the postpartum period: A case report. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 20(2), 169-173.

Clinical effects and pharmacokinetics of the fusion protein PIXY321 in children receiving myelosuppressive chemotherapy
Furman, W. L., Rodman, J. H., Tonda, M. E., Luo, X. L., Arnold, B., & Meyer, W. H. (1998). Clinical effects and pharmacokinetics of the fusion protein PIXY321 in children receiving myelosuppressive chemotherapy. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 41(3), 229-236.

Comparison of cytokines in children with recurrent solid tumors treated with intensive chemotherapy
Furman, W. L., Luo, X. L., Marina, N., Garrison, L., Pratt, C. B., & Meyer, W. H. (1998). Comparison of cytokines in children with recurrent solid tumors treated with intensive chemotherapy. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 20(1), 62-68.

Treatment of children with peripheral primitive neuroectodermal tumor or extraosseous Ewing's tumor with Ewing's-directed therapy
Gururangan, S., Marina, N. M., Luo, X. L., Parham, D. M., Tzen, C. Y., & Meyer, W. H. (1998). Treatment of children with peripheral primitive neuroectodermal tumor or extraosseous Ewing's tumor with Ewing's-directed therapy. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 20(1), 55-61.

Long-term survivors of childhood cancer - The medical consequences of cure
Marina, N. (1997). Long-term survivors of childhood cancer - The medical consequences of cure. PEDIATRIC CLINICS OF NORTH AMERICA, 44(4), 1021-?.

Is primitive neuroectodermal tumor of the kidney a distinct entity?
RodriguezGalindo, C., Marina, N. M., Fletcher, B. D., Parham, D. M., BODNER, S. M., & Meyer, W. H. (1997). Is primitive neuroectodermal tumor of the kidney a distinct entity?. CANCER, 79(11), 2243-2250.

Phase I trial of subcutaneous interleukin-1 alpha in children with malignant solid tumors
Furman, W. L., Luo, X. L., Fairclough, D., Garrison, L., Marina, N., & Meyer, W. H. (1997). Phase I trial of subcutaneous interleukin-1 alpha in children with malignant solid tumors. MEDICAL AND PEDIATRIC ONCOLOGY, 28(6), 444-450.

Biology and treatment of pediatric malignant solid tumors.
Marina, N. M. (1997). Biology and treatment of pediatric malignant solid tumors. Cancer chemotherapy and biological response modifiers, 17, 642-671.

Local control in synchronous bilateral Wilms tumor
Paulino, A. C., Wilimas, J., Marina, N., Jones, D., Kumar, M., & Kun, L. E. (1996). Local control in synchronous bilateral Wilms tumor. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 36(3), 541-548.

Response of pediatric malignant solid tumors following ifosfamide or ifosfamide/carboplatin/etoposide: A single hospital experience
Pratt, C. B., Luo, X. L., Fang, L., Marina, N., Avery, L., & Furman, W. L. (1996). Response of pediatric malignant solid tumors following ifosfamide or ifosfamide/carboplatin/etoposide: A single hospital experience. MEDICAL AND PEDIATRIC ONCOLOGY, 27(3), 145-148.

Sacrococcygeal yolk sac carcinoma: Imaging findings during treatment
Kaste, S. C., Bridges, J. O., & Marina, N. M. (1996). Sacrococcygeal yolk sac carcinoma: Imaging findings during treatment. PEDIATRIC RADIOLOGY, 26(3), 212-219.

St Jude Children's Research Hospital's international outreach program
Ribeiro, R. C., Marina, N., & Crist, W. M. (1996). St Jude Children's Research Hospital's international outreach program. LEUKEMIA, 10(3), 570-574.

Cytomegalovirus causing pericarditis with tamponade in an adolescent with cancer
Razzouk, B. I., Patrick, C. C., & Marina, N. (1996). Cytomegalovirus causing pericarditis with tamponade in an adolescent with cancer. MEDICAL AND PEDIATRIC ONCOLOGY, 26(1), 70-70.

SERIAL PULMONARY-FUNCTION STUDIES IN CHILDREN TREATED FOR NEWLY-DIAGNOSED HODGKINS-DISEASE WITH MANTLE RADIOTHERAPY PLUS CYCLES OF CYCLOPHOSPHAMIDE, VINCRISTINE, AND PROCARBAZINE ALTERNATING WITH CYCLES OF DOXORUBICIN, BLEOMYCIN, VINBLASTINE, AND DACARBAZINE
Marina, N. M., Greenwald, C. A., Fairclough, D. L., Thompson, E. I., Wilimas, J. A., & BOZEMAN, P. M. (1995). SERIAL PULMONARY-FUNCTION STUDIES IN CHILDREN TREATED FOR NEWLY-DIAGNOSED HODGKINS-DISEASE WITH MANTLE RADIOTHERAPY PLUS CYCLES OF CYCLOPHOSPHAMIDE, VINCRISTINE, AND PROCARBAZINE ALTERNATING WITH CYCLES OF DOXORUBICIN, BLEOMYCIN, VINBLASTINE, AND DACARBAZINE. CANCER, 75(7), 1706-1711.

A PHASE-I STUDY OF SULOFENUR IN REFRACTORY PEDIATRIC MALIGNANT SOLID TUMORS
Pratt, C. B., Bowman, L. C., Marina, N., Pappo, A., Avery, L., & Meyer, W. H. (1995). A PHASE-I STUDY OF SULOFENUR IN REFRACTORY PEDIATRIC MALIGNANT SOLID TUMORS. INVESTIGATIONAL NEW DRUGS, 13(1), 63-66.

REFINING THERAPEUTIC STRATEGIES FOR PATIENTS WITH RESISTANT WILMS-TUMOR
Marina, N. M., Wilimas, J. A., Meyer, W. H., Jones, D. P., Douglass, E. C., & Pratt, C. B. (1994). REFINING THERAPEUTIC STRATEGIES FOR PATIENTS WITH RESISTANT WILMS-TUMOR. AMERICAN JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 16(4), 296-300.

RESPONSE OF IMMUNOCOMPROMISED CHILDREN WITH SOLID TUMORS TO A CONJUGATE VACCINE FOR HAEMOPHILUS-INFLUENZAE TYPE-B
Shenep, J. L., Feldman, S., Gigliotti, F., Roberson, P. K., Marina, N., & BRODKEY, T. O. (1994). RESPONSE OF IMMUNOCOMPROMISED CHILDREN WITH SOLID TUMORS TO A CONJUGATE VACCINE FOR HAEMOPHILUS-INFLUENZAE TYPE-B. JOURNAL OF PEDIATRICS, 125(4), 581-584.

LACK OF HERITABILITY IN OVARIAN GERM-CELL MALIGNANCIES
Shulman, L. P., Muram, D., Marina, N., Jones, C., Portera, J. C., & Elias, S. (1994). LACK OF HERITABILITY IN OVARIAN GERM-CELL MALIGNANCIES. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 170(6), 1803-1808.

PHASE-I STUDY OF ESCALATING TARGETED DOSES OF CARBOPLATIN COMBINED WITH IFOSFAMIDE AND ETOPOSIDE IN TREATMENT OF NEWLY-DIAGNOSED PEDIATRIC SOLID TUMORS
Marina, N. M., Rodman, J. H., Murry, D. J., Shema, S. J., Bowman, L. C., & Pratt, C. B. (1994). PHASE-I STUDY OF ESCALATING TARGETED DOSES OF CARBOPLATIN COMBINED WITH IFOSFAMIDE AND ETOPOSIDE IN TREATMENT OF NEWLY-DIAGNOSED PEDIATRIC SOLID TUMORS. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 86(7), 544-548.

PHASE-I STUDY OF TOPOTECAN FOR PEDIATRIC-PATIENTS WITH MALIGNANT SOLID TUMORS
Pratt, C. B., Stewart, C., Santana, V. M., Bowman, L., Furman, W., & Meyer, W. H. (1994). PHASE-I STUDY OF TOPOTECAN FOR PEDIATRIC-PATIENTS WITH MALIGNANT SOLID TUMORS. JOURNAL OF CLINICAL ONCOLOGY, 12(3), 539-543.

PRIMARY MALIGNANCY OF THE SALIVARY-GLAND IN CHILDREN
Rogers, D. A., Rao, B. N., Bowman, L., Marina, N., Fleming, I. D., & Lobe, T. E. (1994). PRIMARY MALIGNANCY OF THE SALIVARY-GLAND IN CHILDREN. JOURNAL OF PEDIATRIC SURGERY, 29(1), 44-47.

SUCCESSFUL TREATMENT OF ACUTE LYMPHOBLASTIC-LEUKEMIA IN A CHILD WITH CYSTIC-FIBROSIS
Gururangan, S., Horner, M., Rodman, J. H., & Marina, N. M. (1994). SUCCESSFUL TREATMENT OF ACUTE LYMPHOBLASTIC-LEUKEMIA IN A CHILD WITH CYSTIC-FIBROSIS. MEDICAL AND PEDIATRIC ONCOLOGY, 22(6), 414-416.

FAILURE OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR TO REDUCE FEBRILE NEUTROPENIA IN CHILDREN WITH RECURRENT SOLID TUMORS TREATED WITH IFOSFAMIDE, CARBOPLATIN, AND ETOPOSIDE CHEMOTHERAPY
Marina, N. M., Shema, S. J., Bowman, L. C., Rodman, J., Douglass, E. C., & Pratt, C. B. (1994). FAILURE OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR TO REDUCE FEBRILE NEUTROPENIA IN CHILDREN WITH RECURRENT SOLID TUMORS TREATED WITH IFOSFAMIDE, CARBOPLATIN, AND ETOPOSIDE CHEMOTHERAPY. MEDICAL AND PEDIATRIC ONCOLOGY, 23(4), 328-334.

USE OF HBA-71 AND ANTI-BETA(2)-MICROGLOBULIN TO DISTINGUISH PERIPHERAL NEUROEPITHELIOMA FROM NEUROBLASTOMA
Pappo, A. S., Douglass, E. C., Meyer, W. H., Marina, N., & Parham, D. M. (1993). USE OF HBA-71 AND ANTI-BETA(2)-MICROGLOBULIN TO DISTINGUISH PERIPHERAL NEUROEPITHELIOMA FROM NEUROBLASTOMA. HUMAN PATHOLOGY, 24(8), 880-885.

CANDIDA-TROPICALIS INFECTIONS IN CHILDREN WITH LEUKEMIA
Flynn, P. M., Marina, N. M., Rivera, G. K., & Hughes, W. T. (1993). CANDIDA-TROPICALIS INFECTIONS IN CHILDREN WITH LEUKEMIA. LEUKEMIA & LYMPHOMA, 10(4-5), 369-376.

A PHASE-I STUDY OF IFOSFAMIDE WITH MESNA GIVEN DAILY FOR 3 CONSECUTIVE DAYS TO CHILDREN WITH MALIGNANT SOLID TUMORS
Pratt, C. B., Meyer, W. H., Douglass, E. C., Bowman, L., Wilimas, J., & Thompson, E. I. (1993). A PHASE-I STUDY OF IFOSFAMIDE WITH MESNA GIVEN DAILY FOR 3 CONSECUTIVE DAYS TO CHILDREN WITH MALIGNANT SOLID TUMORS. CANCER, 71(11), 3661-3665.

ACUTE HYPERSENSITIVITY REACTIONS TO ETOPOSIDE IN A VEPA REGIMEN FOR HODGKINS-DISEASE
Hudson, M. M., Weinstein, H. J., Donaldson, S. S., Greenwald, C., Kun, L., & Link, M. P. (1993). ACUTE HYPERSENSITIVITY REACTIONS TO ETOPOSIDE IN A VEPA REGIMEN FOR HODGKINS-DISEASE. JOURNAL OF CLINICAL ONCOLOGY, 11(6), 1080-1084.

BRAIN METASTASES IN OSTEOSARCOMA - REPORT OF A LONG-TERM SURVIVOR AND REVIEW OF THE ST-JUDE-CHILDRENS-RESEARCH-HOSPITAL EXPERIENCE
Marina, N. M., Pratt, C. B., Shema, S. J., Brooks, T., Rao, B., & Meyer, W. H. (1993). BRAIN METASTASES IN OSTEOSARCOMA - REPORT OF A LONG-TERM SURVIVOR AND REVIEW OF THE ST-JUDE-CHILDRENS-RESEARCH-HOSPITAL EXPERIENCE. CANCER, 71(11), 3656-3660.

PROGRESS IN THE TREATMENT OF ADOLESCENTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA
Rivera, G. K., Pui, C. H., Santana, V. M., Hancock, M. L., Mahmoud, H., & Crist, W. M. (1993). PROGRESS IN THE TREATMENT OF ADOLESCENTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA. CANCER, 71(10), 3400-3405.

PHASE-I STUDY OF ESCALATING TARGETED DOSES OF CARBOPLATIN COMBINED WITH IFOSFAMIDE AND ETOPOSIDE IN CHILDREN WITH RELAPSED SOLID TUMORS
Marina, N. M., Rodman, J., Shema, S. J., Bowman, L. C., Douglass, E., & Pratt, C. (1993). PHASE-I STUDY OF ESCALATING TARGETED DOSES OF CARBOPLATIN COMBINED WITH IFOSFAMIDE AND ETOPOSIDE IN CHILDREN WITH RELAPSED SOLID TUMORS. JOURNAL OF CLINICAL ONCOLOGY, 11(3), 554-560.

NUCLEOSIDE TRANSPORT IN NORMAL AND NEOPLASTIC-CELLS
Belt, J. A., Marina, N. M., Phelps, D. A., & Crawford, C. R. (1993). NUCLEOSIDE TRANSPORT IN NORMAL AND NEOPLASTIC-CELLS. ADVANCES IN ENZYME REGULATION, 33, 235-252.

EFFICACY AND TOXICITY OF MULTIAGENT CHEMOTHERAPY AND LOW-DOSE INVOLVED-FIELD RADIOTHERAPY IN CHILDREN AND ADOLESCENTS WITH HODGKINS-DISEASE
Hudson, M. M., Greenwald, C., Thompson, E., Wilimas, J., Marina, N., & Kun, L. (1993). EFFICACY AND TOXICITY OF MULTIAGENT CHEMOTHERAPY AND LOW-DOSE INVOLVED-FIELD RADIOTHERAPY IN CHILDREN AND ADOLESCENTS WITH HODGKINS-DISEASE. JOURNAL OF CLINICAL ONCOLOGY, 11(1), 100-108.

DIAGNOSIS AND TREATMENT OF THE MOST COMMON SOLID TUMORS IN CHILDHOOD
Marina, N. M., Krance, R., Ribeiro, R. C., & Crist, W. M. (1992). DIAGNOSIS AND TREATMENT OF THE MOST COMMON SOLID TUMORS IN CHILDHOOD. PRIMARY CARE, 19(4), 871-889.

IMPROVED PROGNOSIS OF CHILDREN WITH OSTEOSARCOMA METASTATIC TO THE LUNG(S) AT THE TIME OF DIAGNOSIS
Marina, N. M., Pratt, C. B., Rao, B. N., Shema, S. J., & Meyer, W. H. (1992). IMPROVED PROGNOSIS OF CHILDREN WITH OSTEOSARCOMA METASTATIC TO THE LUNG(S) AT THE TIME OF DIAGNOSIS. CANCER, 70(11), 2722-2727.

LEUKEMIAS AND LYMPHOMAS IN CHILDREN
Ribeiro, R. C., Krance, R., Marina, N. M., & Crist, W. M. (1992). LEUKEMIAS AND LYMPHOMAS IN CHILDREN. PRIMARY CARE, 19(4), 853-869.

TREATMENT OF CHILDHOOD GERM-CELL TUMORS - REVIEW OF THE ST JUDE EXPERIENCE FROM 1979 TO 1988
Marina, N., Fontanesi, J., Kun, L., Rao, B., Jenkins, J. J., & Etcubanas, E. (1992). TREATMENT OF CHILDHOOD GERM-CELL TUMORS - REVIEW OF THE ST JUDE EXPERIENCE FROM 1979 TO 1988. CANCER, 70(10), 2568-2575.

IFOSFAMIDE PLUS ETOPOSIDE IN NEWLY DIAGNOSED EWINGS-SARCOMA OF BONE
Meyer, W. H., Kun, L., Marina, N., Roberson, P., Parham, D., & Pratt, C. B. (1992). IFOSFAMIDE PLUS ETOPOSIDE IN NEWLY DIAGNOSED EWINGS-SARCOMA OF BONE. JOURNAL OF CLINICAL ONCOLOGY, 10(11), 1737-1742.

OVARIAN-CANCER IN CHILDREN AND ADOLESCENTS
Muram, D., GALE, C. L., Thompson, E., & Marina, N. (1992). OVARIAN-CANCER IN CHILDREN AND ADOLESCENTS. ADOLESCENT AND PEDIATRIC GYNECOLOGY, 5(1), 21-26.

CANDIDA-TROPICALIS AND CANDIDA-ALBICANS FUNGEMIA IN CHILDREN WITH LEUKEMIA
Marina, N. M., Flynn, P. M., Rivera, G. K., & Hughes, W. T. (1991). CANDIDA-TROPICALIS AND CANDIDA-ALBICANS FUNGEMIA IN CHILDREN WITH LEUKEMIA. CANCER, 68(3), 594-599.

THE ROLE OF 2ND-LOOK SURGERY IN THE MANAGEMENT OF ADVANCED GERM-CELL MALIGNANCIES
Marina, N. M., Rao, B., Etcubanas, E., Jenkins, J. J., Kun, L., & Thompson, E. I. (1991). THE ROLE OF 2ND-LOOK SURGERY IN THE MANAGEMENT OF ADVANCED GERM-CELL MALIGNANCIES. CANCER, 68(2), 309-315.

INFRARED, THERMISTOR, AND GLASS-MERCURY THERMOMETRY FOR MEASUREMENT OF BODY-TEMPERATURE IN CHILDREN WITH CANCER
Shenep, J. L., ADAIR, J. R., Hughes, W. T., Roberson, P. K., Flynn, P. M., & Marina, N. M. (1991). INFRARED, THERMISTOR, AND GLASS-MERCURY THERMOMETRY FOR MEASUREMENT OF BODY-TEMPERATURE IN CHILDREN WITH CANCER. CLINICAL PEDIATRICS, 30(4), 36-41.

EFFECT OF NUCLEOSIDE TRANSPORT INHIBITORS ON THYMIDINE SALVAGE AND THE TOXICITY OF NUCLEOSIDE ANALOGS IN MOUSE BONE-MARROW GRANULOCYTE-MACROPHAGE PROGENITOR CELLS
Marina, N. M., & Belt, J. A. (1991). EFFECT OF NUCLEOSIDE TRANSPORT INHIBITORS ON THYMIDINE SALVAGE AND THE TOXICITY OF NUCLEOSIDE ANALOGS IN MOUSE BONE-MARROW GRANULOCYTE-MACROPHAGE PROGENITOR CELLS. CANCER COMMUNICATIONS, 3(12), 367-372.

USE OF MR IMAGING TO ASSESS RESULTS OF CHEMOTHERAPY FOR EWING SARCOMA
LEMMI, M. A., Fletcher, B. D., Marina, N. M., SLADE, W., Parham, D. M., & Meyer, W. H. (1990). USE OF MR IMAGING TO ASSESS RESULTS OF CHEMOTHERAPY FOR EWING SARCOMA. AMERICAN JOURNAL OF ROENTGENOLOGY, 155(2), 343-346.

PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR (PERIPHERAL NEUROEPITHELIOMA) IN CHILDREN - A REVIEW OF THE ST JUDE EXPERIENCE AND CONTROVERSIES IN DIAGNOSIS AND MANAGEMENT
Marina, N. M., Etcubanas, E., Parham, D. M., Bowman, L. C., & Green, A. (1989). PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR (PERIPHERAL NEUROEPITHELIOMA) IN CHILDREN - A REVIEW OF THE ST JUDE EXPERIENCE AND CONTROVERSIES IN DIAGNOSIS AND MANAGEMENT. CANCER, 64(9), 1952-1960.